Kirsten J Lum1, Rajeshwari Sundaram, Dana B Barr, Thomas A Louis, Germaine M Buck Louis. 1. From the aDivision of Intramural Population Health Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Rockville, MD; bDepartment of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD; and cDepartment of Environmental Health, Rollins School of Public Health, Emory University, Atlanta, GA.
Abstract
BACKGROUND: Perfluoroalkyl substances have been associated with changes in menstrual cycle characteristics and fecundity, when modeled separately. However, these outcomes are biologically related, and we evaluate their joint association with exposure to perfluoroalkyl substances. METHODS: We recruited 501 couples from Michigan and Texas in 2005-2009 upon their discontinuing contraception and followed them until pregnancy or 12 months of trying. Female partners provided a serum sample on enrollment and completed daily journals on menstruation, intercourse, and pregnancy test results. We measured seven perfluoroalkyl substances in serum using liquid chromatography-tandem mass spectrometry. We assessed the association between perfluoroalkyl substances and menstrual cycle length using accelerated failure time models and between perfluoroalkyl substances and fecundity using a Bayesian joint modeling approach to incorporate cycle length. RESULTS: Menstrual cycles were 3% longer comparing women in the second versus first tertile of perfluorodecanoate (PFDeA; acceleration factor [AF] = 1.03, 95% credible interval [CrI] = [1.00, 1.05]), but 2% shorter for women in the highest versus lowest tertile of perfluorooctanoic acid (PFOA; AF = 0.98, 95% CrI = [0.96, 1.00]). When accounting for cycle length, relevant covariates, and remaining perfluoroalkyl substances, the probability of pregnancy was lower for women in second versus first tertile of perfluorononanoate (PFNA; odds ratio [OR] = 0.6, 95% CrI = [0.4, 1.0]) although not when comparing the highest versus lowest (OR = 0.7, 95% CrI = [0.3, 1.1]) tertile. CONCLUSIONS: In this prospective cohort study, we observed associations between two perfluoroalkyl substances and menstrual cycle length changes, and between select perfluoroalkyl substances and diminished fecundity at some (but not all) concentrations. See video abstract at, http://links.lww.com/EDE/B136.
BACKGROUND:Perfluoroalkyl substances have been associated with changes in menstrual cycle characteristics and fecundity, when modeled separately. However, these outcomes are biologically related, and we evaluate their joint association with exposure to perfluoroalkyl substances. METHODS: We recruited 501 couples from Michigan and Texas in 2005-2009 upon their discontinuing contraception and followed them until pregnancy or 12 months of trying. Female partners provided a serum sample on enrollment and completed daily journals on menstruation, intercourse, and pregnancy test results. We measured seven perfluoroalkyl substances in serum using liquid chromatography-tandem mass spectrometry. We assessed the association between perfluoroalkyl substances and menstrual cycle length using accelerated failure time models and between perfluoroalkyl substances and fecundity using a Bayesian joint modeling approach to incorporate cycle length. RESULTS: Menstrual cycles were 3% longer comparing women in the second versus first tertile of perfluorodecanoate (PFDeA; acceleration factor [AF] = 1.03, 95% credible interval [CrI] = [1.00, 1.05]), but 2% shorter for women in the highest versus lowest tertile of perfluorooctanoic acid (PFOA; AF = 0.98, 95% CrI = [0.96, 1.00]). When accounting for cycle length, relevant covariates, and remaining perfluoroalkyl substances, the probability of pregnancy was lower for women in second versus first tertile of perfluorononanoate (PFNA; odds ratio [OR] = 0.6, 95% CrI = [0.4, 1.0]) although not when comparing the highest versus lowest (OR = 0.7, 95% CrI = [0.3, 1.1]) tertile. CONCLUSIONS: In this prospective cohort study, we observed associations between two perfluoroalkyl substances and menstrual cycle length changes, and between select perfluoroalkyl substances and diminished fecundity at some (but not all) concentrations. See video abstract at, http://links.lww.com/EDE/B136.
Authors: Anne Marie Zaura Jukic; Clarice R Weinberg; Allen J Wilcox; D Robert McConnaughey; Paige Hornsby; Donna D Baird Journal: Am J Epidemiol Date: 2007-10-10 Impact factor: 4.897
Authors: Kurunthachalam Kannan; Simonetta Corsolini; Jerzy Falandysz; Gilberto Fillmann; Kurunthachalam Senthil Kumar; Bommanna G Loganathan; Mustafa Ali Mohd; Jesus Olivero; Nathalie Van Wouwe; Jae Ho Yang; Kenneth M Aldoust Journal: Environ Sci Technol Date: 2004-09-01 Impact factor: 9.028
Authors: David Trudel; Lea Horowitz; Matthias Wormuth; Martin Scheringer; Ian T Cousins; Konrad Hungerbühler Journal: Risk Anal Date: 2008-04 Impact factor: 4.000
Authors: Germaine M Buck Louis; Rajeshwari Sundaram; Enrique F Schisterman; Anne M Sweeney; Courtney D Lynch; Robert E Gore-Langton; José Maisog; Sungduk Kim; Zhen Chen; Dana B Barr Journal: Environ Health Perspect Date: 2012-11-14 Impact factor: 9.031
Authors: Ning Ding; Siobán D Harlow; John F Randolph; Rita Loch-Caruso; Sung Kyun Park Journal: Hum Reprod Update Date: 2020-09-01 Impact factor: 15.610
Authors: Elise L Rush; Alison B Singer; Matthew P Longnecker; Line S Haug; Azemira Sabaredzovic; Elaine Symanski; Kristina W Whitworth Journal: Environ Int Date: 2017-12-20 Impact factor: 9.621
Authors: Linda G Kahn; Kim G Harley; Eva L Siegel; Yeyi Zhu; Pam Factor-Litvak; Christina A Porucznik; Michele Klein-Fedyshin; Alison E Hipwell Journal: Hum Reprod Update Date: 2021-02-19 Impact factor: 15.610
Authors: Suzanne E Fenton; Alan Ducatman; Alan Boobis; Jamie C DeWitt; Christopher Lau; Carla Ng; James S Smith; Stephen M Roberts Journal: Environ Toxicol Chem Date: 2020-12-07 Impact factor: 4.218